R R

What Is an Intraperitoneal Drug?

An intraperitoneal drug is a medicine administered directly into the peritoneal cavity, the potential space between the parietal and visceral layers of the peritoneum. The term describes the route of administration rather than a specific drug class. Medicine can be delivered through a catheter, implanted port, or another approved access method. Intraperitoneal administration can provide high local exposure or allow absorption across the peritoneal lining.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is an Intraperitoneal Drug?

An intraperitoneal drug is a medicine administered directly into the peritoneal cavity, the potential space between the parietal and visceral layers of the peritoneum. The term describes the route of administration rather than a specific drug class. Medicine can be delivered through a catheter, implanted port, or another approved access method. Intraperitoneal administration can provide high local exposure or allow absorption across the peritoneal lining.

read more about intraperitoneal drug ...

Copy this HTML:

Copy HTML Copied!

What Are Intraperitoneal Drugs Used For?

Intraperitoneal medicines are used in selected cancer treatments, particularly when disease involves the peritoneal cavity. Antibiotics can also be placed into peritoneal dialysis fluid to treat peritoneal dialysis-associated infection. Heated intraperitoneal chemotherapy is administered during certain surgical procedures under specialized conditions. The route is also common in laboratory-animal research but is less common than oral or intravenous administration in routine human care.

How Are Intraperitoneal Drugs Absorbed?

A drug placed in the peritoneal cavity can contact local tissues and cross the peritoneal membrane. Absorbed medicine can enter portal or systemic circulation through blood vessels and lymphatic pathways. Molecular size, charge, lipid solubility, formulation, fluid volume, blood flow, and disease within the abdomen can affect absorption. Local exposure can remain higher than blood exposure for some medicines and treatment methods.

How Are Intraperitoneal Drugs Administered?

Administration is performed by trained clinicians using a sterile catheter, port, dialysis system, or surgical technique appropriate for the treatment. The medicine, diluent, concentration, volume, temperature, and dwell time are product and procedure specific. Patient position can be adjusted to help distribute fluid within the abdomen. Vital signs, abdominal symptoms, access function, fluid balance, and treatment response can require monitoring.

What Are the Risks and Safety Considerations?

Potential complications include abdominal pain, nausea, infection, peritonitis, catheter blockage, leakage, and uneven drug distribution. Placement procedures can also cause bleeding or injury to abdominal organs or blood vessels. Some medicine enters the bloodstream and can produce systemic toxicity in addition to local effects. Intraperitoneal administration should be used only for drugs and formulations proven suitable for this route.

Frequently Asked Questions About Intraperitoneal Drugs

Is an intraperitoneal drug injected into the stomach?

No. It is delivered into the peritoneal cavity, not into the stomach or another digestive organ. The peritoneal cavity is the potential space between the parietal and visceral layers of the peritoneum.

Is intraperitoneal administration the same as intravenous administration?

No. Intraperitoneal administration places medicine inside the abdominal cavity, while intravenous administration delivers it directly into a vein. Their absorption, distribution, and risks differ.

Can any injectable drug be given intraperitoneally?

No. The medicine and formulation must be appropriate for the peritoneal route. A product approved for intravenous or intramuscular use should not be given intraperitoneally unless specific clinical guidance supports it.

Can intraperitoneal drugs cause whole-body side effects?

Yes. Medicine can be absorbed from the peritoneal cavity into the circulation. The amount absorbed and resulting systemic effects depend on the drug, dose, formulation, and procedure.

References

WFH Guidelines for the Management of Hemophilia, 3rd Edition. World Federation of Hemophilia. https://www1.wfh.org/publications/files/pdf-1863.pdf. Date Accessed August 6, 2026.

Treatment of Hemophilia. Centers for Disease Control and Prevention. https://www.cdc.gov/hemophilia/treatment/index.html. Date Accessed August 6, 2026.

Hemophilia. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK551607/. Date Accessed August 6, 2026.

Von Willebrand Factor. StatPearls (NCBI Bookshelf). https://www.ncbi.nlm.nih.gov/books/NBK565885/. Date Accessed August 6, 2026.

KCENTRA (Prothrombin Complex Concentrate [Human]): Prescribing Information. U.S. Food and Drug Administration. https://www.fda.gov/media/85512/download. Date Accessed August 6, 2026.